Zotum 750mg Injection contains Cefuroxime, a second-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and septicemia. Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The injectable formulation allows for rapid systemic distribution, making it suitable for moderate to severe infections where oral therapy is not feasible or effective. Dosage and duration of treatment should be determined based on the severity and type of infection, as well as patient-specific factors such as renal function. Common adverse effects may include local injection site reactions, gastrointestinal disturbances, and hypersensitivity reactions. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Renal function monitoring is recommended during prolonged therapy. Zotum 750mg Injection should be administered under the supervision of a healthcare professional, ensuring appropriate dosing and monitoring to optimize therapeutic outcomes and minimize resistance development. It is contraindicated in patients with known hypersensitivity to cefuroxime or other beta-lactam antibiotics.